glp 1 trials Lilly orforglipron oral GLP-1 phase 3 weight loss trial Beyond GLP-1: the next wave
Description
Triple agonists with GLP1, GIP and glucagon Given the efficacy and benefits of the dual GLP-1/GIP RA tirzepatide and the dual GLP-1/glucagon RA, a triple agonist targeting all three receptors (GLP-1/GIP/glucagon) may result in superior WL and glycaemic control than dual agonists
What is most disturbing is the rise in children under the age of 5 who are now overweight or living with obesity
Nature Reviews Disease Primers, 6(1), 3
EClinicalMedicine , 54
The combination of the right foods with GLP-1 medication produces significantly better metabolic outcomes than medication alone
Ozempic is administered just once a week
